IL160886A0 - Nicotine containing pharmaceutical formulations and use thereof - Google Patents

Nicotine containing pharmaceutical formulations and use thereof

Info

Publication number
IL160886A0
IL160886A0 IL16088602A IL16088602A IL160886A0 IL 160886 A0 IL160886 A0 IL 160886A0 IL 16088602 A IL16088602 A IL 16088602A IL 16088602 A IL16088602 A IL 16088602A IL 160886 A0 IL160886 A0 IL 160886A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulations
containing pharmaceutical
nicotine containing
nicotine
formulations
Prior art date
Application number
IL16088602A
Other languages
English (en)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IL160886A0 publication Critical patent/IL160886A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16088602A 2001-09-27 2002-09-10 Nicotine containing pharmaceutical formulations and use thereof IL160886A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof

Publications (1)

Publication Number Publication Date
IL160886A0 true IL160886A0 (en) 2004-08-31

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16088602A IL160886A0 (en) 2001-09-27 2002-09-10 Nicotine containing pharmaceutical formulations and use thereof

Country Status (19)

Country Link
EP (1) EP1429770B1 (xx)
JP (1) JP4262094B2 (xx)
KR (1) KR20040047868A (xx)
CN (1) CN1561213A (xx)
AR (1) AR036679A1 (xx)
AT (1) ATE431144T1 (xx)
AU (1) AU2002334523B2 (xx)
BR (1) BR0212834A (xx)
CA (1) CA2461757C (xx)
DE (1) DE60232344D1 (xx)
DK (1) DK1429770T3 (xx)
ES (1) ES2325684T3 (xx)
IL (1) IL160886A0 (xx)
MX (1) MXPA04002876A (xx)
NZ (1) NZ532528A (xx)
RU (1) RU2282447C2 (xx)
SE (1) SE0103210D0 (xx)
WO (1) WO2003026656A1 (xx)
ZA (1) ZA200402091B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN102669810B (zh) 2003-11-07 2014-11-05 美国无烟烟草有限责任公司 烟草组合物
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
DE60232344D1 (de) 2009-06-25
AR036679A1 (es) 2004-09-29
ES2325684T3 (es) 2009-09-14
CA2461757A1 (en) 2003-04-03
CN1561213A (zh) 2005-01-05
JP4262094B2 (ja) 2009-05-13
MXPA04002876A (es) 2005-06-20
EP1429770A1 (en) 2004-06-23
NZ532528A (en) 2005-10-28
RU2004108853A (ru) 2005-04-20
DK1429770T3 (da) 2009-08-03
ZA200402091B (en) 2005-06-29
WO2003026656A1 (en) 2003-04-03
CA2461757C (en) 2008-09-02
AU2002334523B2 (en) 2007-02-15
BR0212834A (pt) 2004-10-13
RU2282447C2 (ru) 2006-08-27
ATE431144T1 (de) 2009-05-15
EP1429770B1 (en) 2009-05-13
KR20040047868A (ko) 2004-06-05
JP2005503429A (ja) 2005-02-03
SE0103210D0 (sv) 2001-09-27

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
IL160853A0 (en) Nicotine containing formulations and use thereof
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL155088A0 (en) Medicinal aerosol formulations
SI1411921T1 (sl) Farmacevtski sestavki, ki vsebujejo terbinafin, in njihova uporaba
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
HUP0400023A2 (hu) Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
IL153487A0 (en) Pharmaceutical compositions and methods for use
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
IL153897A0 (en) Pharmaceutical compositions and methods for use
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof